Report Examines Access Issues Surrounding Hepatitis C Treatment In Low-, Middle-Income Countries

A new report (.pdf) from the Open Society Foundations, titled, “Hepatitis C Treatment: Price, Profits, and Barriers to Access,” examines “the difference in price of a 48-week course of hepatitis C treatment in low- and middle-income countries, and detail[s] breakthroughs that have been made in countries like Egypt and Thailand to negotiate lower prices and increase access to this lifesaving medicine,” according to the report summary. The WHO “estimates that as many as 185 million people, or three percent of the world’s population, are infected with the hepatitis C virus,” the summary states, adding, “Though it is curable, the vast majority of people living with hepatitis C reside in low- and middle-income countries where treatment is virtually inaccessible” (Momenghalibaf, July 2013).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.